Anebulo Pharmaceuticals (ANEB) Assets (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Assets of $9.4 million for Q4 2025, down 40.52% year-over-year from $15.8 million in Q4 2024, and down 11.95% quarter-over-quarter from $10.7 million in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Assets (2020 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Assets for 6 consecutive years, with $9.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets fell 40.52% year-over-year to $9.4 million; the TTM figure through Dec 2025 stood at $9.4 million (down 40.52% YoY), while the FY2025 annual figure was $12.1 million, up 198.19% from the prior year.
- Assets retreated to $9.4 million in Q4 2025 per ANEB's latest filing, from $10.7 million in the prior quarter.
- Across five years, Assets topped out at $21.7 million in Q2 2021 and bottomed at $2.5 million in Q3 2024.
- Historically, Assets has averaged $12.6 million across 5 years, with a median of $13.1 million in 2025.
- Annual changes were most pronounced in 2021 — Assets surged 615.0% — and 2024, when it slumped 72.72%.
- Anebulo Pharmaceuticals' Assets stood at $19.0 million in 2021, then retreated by 10.95% to $16.9 million in 2022, then plunged by 55.59% to $7.5 million in 2023, then surged by 111.19% to $15.8 million in 2024, then tumbled by 40.52% to $9.4 million in 2025.
- Business Quant data shows ANEB's Assets at $9.4 million in Q4 2025, $10.7 million in Q3 2025, and $12.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | 9.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 10.70 Mn |
| Jun 30, 2025 | 12.15 Mn |
| Mar 31, 2025 | 14.01 Mn |
| Dec 31, 2024 | 15.84 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 7.50 Mn |
| Sep 30, 2023 | 9.05 Mn |
| Jun 30, 2023 | 11.67 Mn |
| Mar 31, 2023 | 14.43 Mn |
| Dec 31, 2022 | 16.89 Mn |
| Sep 30, 2022 | 19.82 Mn |
| Jun 30, 2022 | 15.58 Mn |
| Mar 31, 2022 | 17.25 Mn |
| Dec 31, 2021 | 18.96 Mn |
| Sep 30, 2021 | 20.50 Mn |
| Jun 30, 2021 | 21.65 Mn |
| Mar 31, 2021 | 4.29 Mn |